2 results
Approved WMORecruiting
To test the hypothesis that LY3314814, administered orally at doses of 20 and 50 mg daily for 78 weeks, will slow the decline of AD ascompared with placebo in patients with mild AD dementia.
Approved WMORecruiting
The primary objective is:• to study the effect of icosapent ethyl on progression of aortic valve calcification.The secondary objectives are:• to study the effect of icosapent ethyl on progression of aortic valve stenosis.• to study the effect of…